Sopharma AD-Sofia (XBUL:SFA) 3-Year EPS without NRI Growth Rate : 31.20% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia 3-Year EPS without NRI Growth Rate?

Sopharma AD-Sofia's EPS without NRI for the three months ended in Dec. 2023 was лв0.08.

During the past 12 months, Sopharma AD-Sofia's average EPS without NRI Growth Rate was 4.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 31.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Sopharma AD-Sofia was 41.50% per year. The lowest was -18.60% per year. And the median was 4.25% per year.

Competitive Comparison of Sopharma AD-Sofia's 3-Year EPS without NRI Growth Rate

For the Medical Distribution subindustry, Sopharma AD-Sofia's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma AD-Sofia's 3-Year EPS without NRI Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's 3-Year EPS without NRI Growth Rate falls into.

Sopharma AD-Sofia 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Sopharma AD-Sofia (XBUL:SFA) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Sopharma AD-Sofia 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (XBUL:SFA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines